Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intranasal Retinoic Acid Treatment for Patients With Olfactory Loss: A Randomized Controlled Trial

NCT03574701 is registered in ClinicalTrials.gov with St. Paul's Hospital, Canada as lead sponsor.

NCT NCT03574701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03574701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intranasal Retinoic Acid Treatment for Patients With Olfactory Loss: A Randomized Controlled Trial
Lead sponsor
St. Paul's Hospital, Canada
Phase
Not applicable
Overall status
Unknown status
Start date
May 25, 2016
Completion date
December 25, 2022
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

olfactory disorder